Sodium nitroprusside and l-arginine attenuates ferric nitrilotriacetate-induced oxidative renal injury in rats

Toxicology

Volumn 232, Issue 3, 2007, Pages 183-191

  Gupta, Amit ^a   Chander, Vikas ^a   Sharma, Sameer ^a   Chopra, Kanwaljit ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

l Arginine; l NAME; Nitric oxide; Renal failure; Sodium nitroprusside; Tumor necrosis factor

Indexed keywords

ARGININE; CREATININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; NITRILOTRIACETATE IRON; NITROPRUSSIDE SODIUM; TUMOR NECROSIS FACTOR ALPHA; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ARGININE; BLOOD UREA NITROGEN; CREATININE; DRUG INTERACTIONS; ENZYME INHIBITORS; FERRIC COMPOUNDS; GLUTATHIONE; HISTOCYTOCHEMISTRY; KIDNEY DISEASES; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRILOTRIACETIC ACID; NITROPRUSSIDE; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 33947330768     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2007.01.009     Document Type: Article

References (52)

1. Aggarwal A., and Nick H.S. Renal response to tissue injury: lessons from heme oxygenase-1 ablation and expression. J. Am. Soc. Nephrol. 11 (2000) 965-973
2. Ahmad N.S., Khalid B.A., Luke D.A., and Ima Nirwana S. Tocotrienol offers better protection than tocopherol from free radical-induced damage of rat bone. Clin. Exp. Pharmacol. Physiol. 32 9 (2005) 761-770
3. Aruoma O.I., Halliwell B., Gajewski E., and Dizdaroglu M. Damage to the bases in DNA induction by hydrogen peroxide and ferric ion chelates. J. Biol. Chem. 264 (1989) 20509-20512
4. Awai M., Narasaki M., Yamanoi Y., and Seno S. Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. A model of experimental hemochromatosis. Am. J. Pathol. 95 (1979) 663-673
5. Chen L., Wang Y., et al. Molecular mechanisms by which iron induces nitric oxide synthesis in cultured proximal tubule cells. Exp. Nephrol. 9 3 (2001) 198-204
6. Chintala M.S., Chiu P.J., Vemulapalli S., Watkins R.W., and Sybertz E.J. Inhibition of endothelial derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized rats. Naunyn Schmiedebergs Arch. Pharmacol. 348 (1993) 305-310
7. Clancy R.M., Leszczynska-Piziak J., and Abramson S.B. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest. 90 (1992) 1116-1121
8. Di Rosa M., Radomski M., Carnuccio R., and Moncada S. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem. Biophys. Res. Commun. 172 (1990) 1246-1252
9. Dobashi K., Singh I., Orak J.K., Asayama K., and Singh A.K. Combination therapy of N-acetylcysteine, sodium nitroprusside and phosphoramidon attenuates ischemia-reperfusion injury in rat kidney. Mol. Cell Biochem. 240 1/2 (2002) 9-17
10. Ebina Y., Okada S., Hamazaki S., Ogino F., Li J.L., and Midorikawa O. Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriactetate complexes in rats. J. Natl. Cancer Inst. 76 (1986) 107-113
11. Grisham M.B. Interaction between nitric oxide and superoxide role in modulating leukocyte adhesion in the post-ischemic microvasculature. Transplant Proc. 27 (1995) 2842-2843
12. Guder W.G., and Ross B.D. Enzyme distribution along the nephron. Kidney Int. 26 (1984) 101-111
13. Guilivi C., Podoroso J.J., and Boveris A. Production of nitric oxide by mitochondria. J. Biol. Chem. 78 (1998) 11038-11043
14. Hamazaki S., Okada S., Ebina Y., and Midorikawa O. Acute renal failure and glycosuria induced by ferric nitrilotriacetate in rats. Toxicol. Appl. Pharmacol. 77 (1985) 267-274
15. Hibbs J.B., Taintor R.R., and Vavrin Z. Macrophage cytotoxicity: role for l-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235 (1987) 473-476
16. Hiroyasu M., Ozeki M., Kohda H., Echizenya M., Tanaka T., Hiai H., and Toyokuni S. Specific allelic loss of p16 (INK4A) tumor suppressor gene after weeks of iron-mediated oxidative damage during rat renal carcinogenesis. Am. J. Pathol. 160 (2002) 419-424
17. Iqbal M., Okazaki Y., Sharma S.D., and Okada S. Nitroglycerin, a nitric oxide generator attenuates ferric nitrilotriacetate-induced renal oxidative stress, hyperproliferative response and necrosis in ddY mice. Biochem. Biophys. Acta 1623 2/3 (2003) 98-108
18. Jacobs A. In: Jacobs A., and Worwood M. (Eds). Iron in Biochemistry and Medicine, II (1980), Academic Press, New York/London 427-459
19. Jollow D.J., Mitchell L.R., Zampaglione N., and Gillete J.R. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzeneoxide as the hepatotoxic intermediate. Pharmacology 11 (1974) 151-169
20. Jyothi M.D., and Khar A. Induction of nitric oxide production by natural killer cells: its role in tumor cell death. Nitric Oxide 3 (1999) 409-418
21. Kadkhodaee M.a.G.A. The role of nitric oxide in iron-induced rat renal injury. Hum. & Exp. Toxicol. 23 (2004) 533-536
22. Kagan V.E., Kozlov A.V., Tyurina Y.Y., Shvedova A.A., and Yalowich J.C. Antioxidant mechanisms of nitric oxide against iron-catalyzed oxidative stress in cells. Antioxid. Redox Signal 3 2 (2001) 189-202
23. King A.J., Troy J.L., Anderson S., Neuringer J.R., Gunning M., and Brenner B.M. Nitric oxide: a potential mediator of amino acid-induced renal hyperemia and hyperfiltration. J. Am. Soc. Nephrol. 1 (1991) 1271-1277
24. Koppenol W.H. The Haber-Weiss cycle-70 years later. Redox Rep. 6 (2001) 229-234
25. Kowaluk E.A., Seth J., and Fung H.L. Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J. Pharmacol. Exp. Ther. 262 (1992) 916-922
26. Krepinsky J.C., Ingram A.J., et al. Nitric oxide inhibits stretch-induced MAPK activation in mesangial cells through RhoA inactivation. J. Am. Soc. Nephrol. 14 11 (2003) 2790-2800
27. Kurus M., Esrefoglu M., Bay A., and Ozturk F. Protective effect of oral l-arginine supplementation on cyclosporine induced nephropathy in rats. Int. Urol. Nephrol. 37 3 (2005) 587-594
28. Liochev S.I., and Fridovich I. The Haber-Weiss cycle-70 years later: an alternative view. Redox Rep. 7 (2002) 55-57
29. Majid D., and Navar L.G. Nitric oxide in the control of renal hemodynamics and excretory function. Am. J. Hypertens. 14 (2001) 74S-82S
30. Matsumura Y., Nishiura M., et al. Protective effect of FK409, a spontaneous nitric oxide releaser, on ischemic acute renal failure in rats. J. Pharmacol. Exp. Ther. 287 3 (1998) 1084-1091
31. Mehta A., Sekhon C.P., Giri S., Orak J.K., and Singh A.K. Attenuation of ischemia/reperfusion induced MAP kinases by N-acetyl cysteine, sodium nitroprusside and phosphoramidon. Mol. Cell Biochem. 240 1/2 (2002) 19-29
32. Minhajuddin M., Beg Z.H., and Iqbal J. Hypolipidemic and antioxidant properties of tocotrienol rich fraction isolated from rice bran oil in experimentally induced hyperlipidemic rats. Food Chem. Toxicol. 43 5 (2005) 747-753
33. Moncada S., and Higgs A. The l-arginine -nitric oxide pathway. N. Engl. J. Med. 329 (1993) 2002-2012
34. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979) 351-358
35. Okada S. Iron induced tissue damage and cancer: the role of reactive oxygen species-free radicals. Pathol. Int. 46 (1996) 311-332
36. Okada S., and Midorikawa O. Induction of rat renal adenocarcinoma by Fe-nitrilotriacetate (Fe-NTA). Jpn. Arch. Intern. Med. 29 (1982) 485-491
37. Preece N.E., Evans P.E., Howarth J.A., King L.J., and Parke D.V. The induction of antioxidative tissue damage by iron nitrilotriactetate in rats and mice. Toxicol. Appl. Pharmacol. 93 (1985) 89-100
38. Seçilmia M.A., Karataa Y., Yorulmaza O., Büyükafarb K., Erginingirika, Doranc F., Inald T.C., and Dikmena A. Protective Effect of l-arginine Intake on the Impaired Renal Vascular Responses in the Gentamicin-Treated rats. Nephron Physiol. 100 (2005) p13-p20
39. Sekhon C.S., Sekhon B.K., Singh I., Orak J.K., and Singh A.K. Attenuation of renal ischemia/reperfusion injury by a triple drug combination therapy. J. Nephrol. 16 1 (2003) 63-74
40. Shimoi K., Shen B., Toyokuni S., Mochizuki R., Furugori, and Kinae N. Protection by αG-Rutin, a water-soluble antioxidant flavonoid, against renal damage in mice treated with ferric nitrilotriacetate. Jpn. J. Caner Res. 88 (1997) 453-460
41. Singh R.J., Hogg N., et al. The peroxynitrite generator, SIN-1, becomes a nitric oxide donor in the presence of electron acceptors. Arch. Biochem. Biophys. 361 2 (1999) 331-339
42. Taso B., and Curthoys N.P. The absolute asymmetry of orientation of gamma-glutamyltranspeptidase and amino-peptidase on the external surface of the rat renal brush order membrane. J. Biol. Chem. 255 (1980) 7708-7711
43. Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radic. Biol. Med. 20 (1996) 553-566
44. Toyokuni S. Iron and carcinogenesis: from Fenton reaction to target genes. Redox Rep. 7 4 (2002) 189-197
45. Toyokuni S., Uchida K., Okamoto K., Nakakuki Y.H., Hiai H., and Standman E.R. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 2616-2620
46. Umemura T.Y., Sai K., Takagi A., Hasegawa R., and Kurakawa Y. Oxidative DNA damage, lipid peroxidation and nephrotoxicity induced in rat kidney after ferric nitrilotriacetate administration. Cancer Lett. 54 (1990) 95-100
47. Valdivielso J.M., and Blantz R.C. Acute renal failure: is nitric oxide the bad guy?. Antioxid. Redox Signal 4 (2002) 925-934
48. Varley H. The plasma proteins. In: Varley H. (Ed). Practical Clinical Biochemistry (1988), CBS, Delhi 183-186
49. Wang H., Carretero O.A., and Garvin J.L. Nitric oxide produced by THAL nitric oxide synthase inhibits TGF. Hypertension 39 (2002) 662-666
50. Waz W.R., Van-Liew J.B., and Feld L.G. Nitric oxide metabolism following unilateral renal ischemia/reperfusion injury in rats. Pediatr. Nephrol. 12 (1998) 26-29
51. Wu Z., and Qiu L. Effect of nitric oxide on iron-mediated cytotoxicity in primary cultured renal proximal tubules. Cell Biochem. Funct. 19 4 (2001) 237-247
52. Yang C.W., Kim Y.S., Kim J., Kim Y.O., Min S.Y., Choi E.J., and Bang B.K. Oral supplementation of l-arginine prevents chronic cyclosporine nephrotoxicity in rats. Exp. Nephrol. 6 1 (1998) 50-56